ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B02BD02 | BioTech | Moroctocog alfa - 250IU | 8849 | 46216/1 | XYNTHA | 250IU | 1+1 | Injectable lyophilised powder for solution+diluent | Infusion | Food & Drug Corporation FDC | Wyeth Farma SA | Spain | 2,962,925 L.L | 19.35 | D | pfizer Canada ULC | Canada | 05/02/20 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B02BD02 | BioTech | Coagulation Factor VIII recombinant (Octocog alfa) - 250IU | 8910 | 127716/1 | RECOMBINATE | 250IU | 1 | Injectable powder for solution+diluent | Infusion/IV | Abela Frères S.A.L. | Baxalta Belgium Manufacturing SA | Belgium | 8,140,612 L.L | 19.35 | D | Baxalta Innovations GmbH | Austria | 05/02/20 |